Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Generic-Drug Maker Viatris a Keeper?

TheMotleyFool

0 0

In this video from Motley Fool Live, recorded on April 5, Fool.com Contributors Brian Orelli and Keith Speights discuss a question from a member named Angel, who asks whether Viatris (NASDAQ: VTRS) is worth holding. The duo discuss Viatris' prospects and the type of investor that is most appropriate for holding the generic-drug maker.

Source Fool.com

Like: 0

VTRS

Share